SAN FRANCISCO, June 19, 2015 /PRNewswire/ -- Sense.ly, the virtual nurse platform for patient engagement and chronic disease monitoring announced at the Digital Health Summer Summit today that it has raised $2.2 million in a Series A round of funding, with investors including Launchpad Digital Health, Fenox Venture Capital, and TA Ventures. Sense.ly will leverage the new round of funding to launch new markets, expand its support of its global customer base, and drive enhancements to its award-winning product, particularly in artificial intelligence and machine learning.
Sense.ly's mobile-first virtual nurse, Molly, engages patients with natural conversation through a wide variety of circumstances from simple administrative needs through complex chronic conditions requiring medical assistance. Aided by Molly, patients can take their vitals measurements; chat about their pain, sleep, stress, and diet; or be connected to an attending physician via video call, if patients show elevated risks.
"We see tremendous potential in using Sense.ly's innovative technology to enable our entire Clinical Commissioning Group to achieve better outcomes at a lower cost for our most highly prevalent conditions such as hypertension and depression," said Paul Maybach, CEO, NHS Dudley CCG. "Our patients' experience to date using the product has been extremely positive and we are anticipating to deploy the technology across the entire organization."
Dr. Jonathan Darby, (General Practitioner, Halesowen, West Midlands) added: "I am convinced Sense.ly technology will help patients navigate the NHS better, help clinicians manage demand more efficiently and provide invaluable support to doctors in helping to monitor and manage many medical conditions in a far more convenient way for patients, doctors and nurses alike."
Sense.ly also announced new customers and partners that have deployed the service including the National Health Service of the UK, Dudley CCG, Novartis, and UCSF. Sense.ly's intuitive interface is available in English, Spanish, and Mandarin, along with 24 other languages, supporting health care administration in various regions of the United States as well as many countries around the world.
"Our steadily growing customer base and revenue combined with this current equity raise gives us the runway to intelligently scale the business, reach new geographies, and accelerate product development to reach our vision of providing the highest quality patient care at dramatically lower costs," said Adam Odessky, Sense.ly's Co-Founder and CEO.
"The powerful combination of consumer facing healthcare, machine learning, and artificial intelligence is already making a deep impact in keeping patients healthier and providers less burdened," said Fred Toney, Partner, Launchpad Digital Health. "Launchpad Digital Health is thrilled to have partnered with Sense.ly in its mission to creatively disrupt the healthcare system."
Sense.ly offers a breakthrough "virtual nurse" patient engagement solution that provides proven, personalized monitoring and follow-up care with a strong focus on patients with chronic diseases. The Sense.ly solution combines innovative avatar-based technology, advanced sensor capabilities, and telemedicine features that generate actionable, real-time data and intelligent analytics, enabling clinicians to make better, timelier care decisions. Sense.ly's solution has won many awards including winning the American Heart Association Health Tech competition, Novartis mHealth Challenge, and Allscripts Open API Challenge. Its customers are some of the most prominent medical institutions in the world including University of California – San Francisco and the National Health Service of the UK. For more information, visit www.sense.ly.
Dr. Ivana Schnur
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sensely-raises-22-million-in-series-a-funding-launchpad-digital-health-leads-investment-to-open-new-markets-and-drive-product-enhancements-300101841.html